Tiverton Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$5.02M Buy
55,692
+23,118
+71% +$2.08M 0.17% 118
2019
Q2
$2.75M Buy
32,574
+1,739
+6% +$147K 0.1% 172
2019
Q1
$2.72M Buy
30,835
+7,481
+32% +$659K 0.12% 147
2018
Q4
$1.67M Buy
+23,354
New +$1.67M 0.1% 135